Drugs / Arnica montana

Trials 4

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00405626 Apr → Sep 2007 hemorrhagic disease Hadassah Medical Organization Unknown No outcome recorded
Phase 31 trial
Phase 3 NCT00222365 Dec 2003 → May 2006 — University Hospital, Grenoble Terminated No outcome recorded
Phase not applicable2 trials
— NCT07445568 Sep 2025 osteoarthritis, knee Universidad del Valle de México, Campus Cuernavaca Completed No outcome recorded
— NCT06193720 Feb 2022 → Aug 2023 — Saint-Joseph University Completed No outcome recorded
Comparator or background therapy5 trials
Phase 1 NCT00504010 Comparator Aug 2007 → Sep 2008 — The University of Texas Health Science Center, Houston Completed No outcome recorded
Phase 3 NCT01156194 Comparator Jan 2011 → Jan 2012 — Shaare Zedek Medical Center Completed No outcome recorded
Phase 4 NCT04534426 Comparator Dec 2018 → Dec 2019 impacted teeth, multiple Abant Izzet Baysal University Completed No outcome recorded
— NCT03512639 Comparator Jan 2016 → Aug 2017 — Shaare Zedek Medical Center Completed No outcome recorded
— NCT01164644 Comparator Jun 2010 → Dec 2012 — University of Wisconsin, Madison Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as Arnica montana “Homeopathic medication (Arnica montana and the Bellis perennis) were given to women in the study group following mastectomy and reconstruction to reduce post operative seroma” NCT03512639 ↗
8

“Arnica montana C6 and Bellis perennis C6” NCT01156194 ↗

NCT00405626 ↗

NCT00222365 ↗

NCT04534426 ↗

NCT06193720 ↗

NCT07445568 ↗

NCT00504010 ↗

NCT01164644 ↗

Modality Traditional medicine (herbal / TCM) “homeopathic drug” NCT00222365 ↗
Route Topical “topical gel formulation” NCT00504010 ↗